Sign up to save your podcasts
Or
Share Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow
Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies?
Credit available for this activity expires: 11/7/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523
View all episodes
By Medscape Podcasts
4
77 ratings
Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies?
Credit available for this activity expires: 11/7/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523
More shows like Keeping Current
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
882 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Annals On Call Podcast
191 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
26 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
372 Listeners